The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Ott, Jördis J ^a   Stevens, Gretchen A ^a   Wiersma, Steven T ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Epidemiology; Hepatitis B e antigen (HBeAg); Hepatitis B virus; Perinatal transmission; Prevalence; Systematic review

Indexed keywords

HEPATITIS B(E) ANTIGEN;

AFRICA; AGE; ARTICLE; BAYES THEOREM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MORTALITY; PACIFIC ISLANDS; PERINATAL PERIOD; RISK ASSESSMENT; SEROPREVALENCE; SOUTHEAST ASIA; STATISTICAL MODEL; SYSTEMATIC REVIEW (TOPIC); VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES; WORLD HEALTH; YOUNG ADULT;

EID: 84861957437     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-131     Document Type: Article

References (37)

1. World Health Organization Hepatitis B vaccines. Weekly epidemiological record 2009 2009, 20-405. , , World Health Organization.
2. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM, Janssen RS, Ward JW, . Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006, 55(RR-16):1-33. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).
3. Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol 2011, 46:1-8.
4. Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009, 19:231-234. 10.1016/j.annepidem.2009.01.017, 19344859.
5. Dwivedi M, Misra SP, Misra V, Pandey A, Pant S, Singh R, Verma M. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011, 30:66-71. 10.1007/s12664-011-0083-y, 21499863.
6. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996, 117:313-325. 10.1017/S0950268800001497, 2271713, 8870629.
7. Knorr B, Maul H, Schnitzler P. Prevalence of hepatitis B virus infection among women at reproductive age at a German university hospital. J Clin Virology 2008, 42:422-4.
8. Shao ZJ, Zhang L, Xu JQ, Xu DZ, Men K, Zhang JX, Cui HC, Yan YP. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol 2011, 83:791-5. 10.1002/jmv.22043, 21360547.
9. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow up study. J Pediatr 1998, 133:374-7. 10.1016/S0022-3476(98)70272-0, 9738719.
10. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA, Levy MT. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009, 190:489-92.
11. Shikata T, Karasawa T, Abe K, et al. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 1977, 136:571-6. 10.1093/infdis/136.4.571, 908854.
12. Alter HJ, Seeff LB, Kaplan PM, et al. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 1976, 295:909-13. 10.1056/NEJM197610212951701, 967200.
13. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977, 105:94-8.
14. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007, 12:160-167. 10.1016/j.siny.2007.01.013, 17336170.
15. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985, 151:599-603. 10.1093/infdis/151.4.599, 3973412.
16. Chang MH, Sung JL, Lee CY, et al. Factors affecting clearance of hepatitis Be antigen in hepatitis B surface antigen carrier children. J Pediatr 1989, 115:385-390. 10.1016/S0022-3476(89)80836-4, 2769497.
17. Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol 2011, 55:183-191. 10.1016/j.jhep.2010.12.030, 21238520.
18. Grosheide PM, Wladimiroff JW, Heijtink RA, Mazel JA, Christiaens GCML, Nuijten ASM, Schaldm SW, . the Dutch Study Group on Prevention of Neonatal hepatitis Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. BMJ 1995, 311:99-1197. 10.1136/bmj.311.6997.99, 2550152, 7613411, the Dutch Study Group on Prevention of Neonatal hepatitis.
19. Op de Coul EL, Hahne S, van Weert YW, Oomen P, Smit C, van der Ploeg KP, Notermans DW, Boer K, Van der Sande MA. Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis 2011, 11:185. 10.1186/1471-2334-11-185, 3160399, 21718466.
20. Global Burden of Diseases, Injuries and Risk Factors Study 2005 Global Burden of Diseases, Injuries and Risk Factors Study operations manual (final draft, January 2009) 2009, Available from http://www.globalburden.org, Global Burden of Diseases, Injuries and Risk Factors Study 2005.
21. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HbsAg seroprevalence and endemicity. Accepted for publication in Vaccine, in press.
22. DISMOD III 2011, http://winthrop.ihme.washington.edu/public/ DISMOD III complete repository of the DisMod code: https://github.com/aflaxman/gbd/tree/master/dismod3, data modeled in June 2011, DISMOD III.
23. Beckers K, Schaad UB, Heininger U. Compliance with antenatal screening for hepatitis B surface antigen carrier status in pregnant women and consecutive procedures in exposed newborns. Eur J Pediatr 2004, 163:654-657.
24. Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 1995, 22:1387-1392.
25. Oshitani H, Kasolo FC, Mpabalwani M, Mizuta K, Luo NP, Suzuki H, Numazaki Y. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996, 90:235-236. 10.1016/S0035-9203(96)90227-8, 8758060.
26. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003, 37:19-26. 10.1053/jhep.2003.50036, 12500184.
27. Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002, 122:1756-1762. 10.1053/gast.2002.33588, 12055581.
28. Chu CM, Liaw YF. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol 2005, 43:411-417. 10.1016/j.jhep.2005.03.018, 16006001.
29. Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007, 133:1452-1457. 10.1053/j.gastro.2007.08.010, 17920063.
30. Olinger CM, Venard V, Njayou M, Oyefolu AO, Maïga I, Kemp AJ, Omilabu SA, le Faou A, Muller CP. Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 2006, 87:1163-1173. 10.1099/vir.0.81614-0, 16603517.
31. Tanaka Y, Hasegawa I, Kato T, Orito E, Hirashima N, Acharya SK, Gish RG, Kramvis A, Kew MC, Yoshihara N, Shrestha SM, Khan M, Miyakawa Y, Mizokami M. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 2004, 40:747-755. 10.1002/hep.20365, 15349915.
32. Cho LY, Yang JJ, Ko KP, Park B, Shin A, Lim MK, Oh JK, Park S, Kim YJ, Shin HR, Yoo KY, Park SK. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. Int J Cancer 2011, 128:176-184. 10.1002/ijc.25321, 20232388.
33. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ. Taiwan Community-Based Cancer Screening Project Group. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002, 347:168-174. 10.1056/NEJMoa013215, 12124405.
34. Wiersma ST, McMahon B, Pawlotsky JM, et al. Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus. Liver Int 2010, [Epub ahead of print].
35. Guidozzi F, Schoub BD, Johnson S, Song E. Should pregnant urban south African women be screened for hepatitis B?. S Afr Med J 1993, 83:103-5.
36. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med 1999, 45:195-8.
37. Sriprakash I, Anil TP. Routine prenatal screening of Indian women for HBsAg: benefits derived versus cost. Trop Doct 1997, 27:176-7.